New partnership between agomelatine and a noradrenaline reuptake Inhibitor, and Pharmaceutical compositions containing it

摘要

The present Invention relates to a New partnership between agomelatine and a noradrenaline reuptake inhibitor agent or any Agent capable of increasing the concentration of extracellular norepinephrine level for the production of pharmaceutical compositions useful in the treatment of The deresion and more particularly in the treatment of resistant Depression.